PRN: Testosterone Replacement Therapy Market (2016-2021) - Globally Increasing Population with Testosterone Deficiency - Research and Markets

07/feb/2017 20:10:22 PR Newswire Turismo Contatta l'autore

Questo comunicato è stato pubblicato più di 1 anno fa. Le informazioni su questa pagina potrebbero non essere attendibili.

Testosterone Replacement Therapy Market (2016-2021) - Globally Increasing Population with Testosterone Deficiency - Research and Markets


DUBLIN, Feb. 7, 2017 /PRNewswire/ --

Research and Markets has announced the addition of the "Testosterone Replacement Therapy Market: By Therapies (Injections, Pallets, Gels, Patches) & By Region (North America, Europe, Asia-Pacific)-Forecast (2016-2021)" report to their offering.

Testosterone replacement therapy (TRT), also known as Androgen replacement therapy (ART), is a class of hormone replacement therapy in which androgens, often testosterone, are replaced to treat conditions in which the testes do not produce enough testosterone due to absence, injury, or disease. Testosterone deficiency amongst men above the age of 30 years is becoming a common problem nowadays due to life style changes and is characterized by fewer erections, fatigue, thinning skin, declining muscle mass and strength, more body fat.

Globally increasing population with testosterone deficiency is expected to remain key growth driver during the period of study. However, side effects of the testosterone replacement therapies are expected to be a key challenge for the industry players during the same time.

Geographically, North America dominates the testosterone replacement therapy market driven by best in class infrastructure, easy access to healthcare, higher awareness about the disease amongst citizens as well as practitioners, and higher spending by the citizens towards healthcare expenditure. North America was followed by Europe and Asia-Pacific as second and third largest markets for testosterone replacement therapy market. Asia Pacific is projected to have the fastest growth, owing to rapidly developing medical infrastructure, increasing medical tourism, increased spending, and increasing awareness amongst population in developing nations such as China and India in this region.

Companies Mentioned:

  • Acrux Limited
  • Actavis Inc.
  • Antares Pharma Inc.
  • Bayer HealthCare Pharmaceuticals
  • Columbia Laboratories Inc.
  • Eli Lilly and Company
  • Endo Pharmaceuticals Inc.
  • ProStrakan Group Plc.
  • Juniper Pharmaceuticals
  • Pfizer Inc.

Key Topics Covered:

1. Market Overview

2. Executive Summary

3. Market Landscape

4. Market Forces

5. Strategic Analysis

6. Testosterone Replacement Therapy Market, By Therapies

7. Testosterone Replacement Therapy Market, By Geography

8. Testosterone Replacement Therapy Market Entropy

9. Company Profiles

10. Appendix

For more information about this report visit

Media Contact:

Laura Wood, Senior Manager

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716


blog comments powered by Disqus è un servizio offerto da Factotum Srl